Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners

BOTHELL, Wash., March 31 /PRNewswire-FirstCall/ -- Cardiac Science
Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis,
resuscitation, rehabilitation, and informatics products, announced today at
the 2008 American College of Cardiology conference that it completed
certification for its HeartCentrix(R) ECG informatics software with NextGen
Healthcare Information Systems. NextGen is a leading developer and provider of
computer-based practice management and electronic medical record (EMR) systems
for medical group practices and healthcare systems.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)
Featuring the industry's most robust cardiology knowledgebase, the NextGen
EMR system is used by more than 1,500 clients nationwide -- including many
leading cardiology practices. These current clients, as well as future
clients, will be readily able to take advantage of connectivity to the
HeartCentrix(R) informatics software. In addition, the integration will be
leveraged through the tens of thousands in Cardiac Science's installed base of
customers.
Designed to integrate seamlessly EMR and other information systems,
HeartCentrix solutions help streamline workflow in multiple health care
environments. HeartCentrix -- which enables seamless data transfer from
Burdick(R) and Quinton(R) electrocardiograph (ECG) devices, cardiac stress,
and Holter monitoring devices to physician EMR software -- can be installed
with a new NextGen EMR implementation, or just as easily into an existing
NextGen account.
Tony Titus, Cardiac Science vice president of marketing, reported that
HeartCentrix and NextGen recently began deployment for their first joint
installation, a multi-site cardiology practice of more than 60 physicians.
"Pairing HeartCentrix with NextGen connects diagnostic devices and EMR systems
together for office-wide efficiencies, and a greater ROI on the EMR
investment," he said.
"HeartCentrix is a great solution for our clients who rely on Burdick and
Quinton diagnostic devices in particular," said Debra Dore, director of
cardiology products for NextGen. "Bringing information from HeartCentrix into
the NextGen EMR platform will enable a smoother office workflow, faster
diagnosis and therapeutic decision-making and, ultimately, better patient
care."
About NextGen
NextGen Healthcare Information Systems, Inc. a wholly owned subsidiary of
Quality Systems, Inc. (Nasdaq: QSII), develops and markets computer-based
practice management and electronic medical records systems for medical group
practices and healthcare systems. For more information about NextGen, please
visit http://www.nextgen.com and http://www.qsii.com.
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced
diagnostic and therapeutic cardiology devices and systems, including automated
external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac
stress systems and treadmills, Holter monitoring systems, hospital
defibrillators, cardiac rehabilitation telemetry systems, and cardiology data
management systems (informatics) that connect with hospital information (HIS),
electronic medical record (EMR), and other information systems. The Company
sells a variety of related products and consumables, and provides a portfolio
of training, maintenance, and support services. Cardiac Science, the successor
to the cardiac businesses that established the trusted Burdick(R),
HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in
Bothell, Washington. With customers in more than 100 countries worldwide, the
company has operations in North America, Europe, and Asia. For information,
call 425.402.2000 or visit http://www.cardiacscience.com.
Forward Looking Statements
This press release contains forward-looking statements. These statements
and their underlying assumptions involve a number of risks and uncertainties
and are not guarantees of future performance. These are forward-looking
statements for purposes of the safe harbor provisions under the Private
Securities Litigation Reform Act of 1995. The words "believe," "expect,"
"intend," anticipate," variations of such words, and similar expressions
identify forward-looking statements, but their absence does not mean that the
statement is not forward looking. Actual results may vary significantly from
the results expressed or implied in such statements. Forward looking
statements in this press release include those that infer or imply that the
revenue and profits of Cardiac Science may increase as a result of the
connectivity of its products with those of NextGen Healthcare Information
Systems and other information systems, as well as other risks that are more
fully described in the Annual Report on Form 10-K filed by Cardiac Science
Corporation for the year ended December 31, 2007. Cardiac Science Corporation
undertakes no duty or obligation to update the information provided herein.
Company Contact: Investor Contact: Media Contact:
Mike Matysik Jenifer Kirtland Christopher Gale
Cardiac Science Corporation EVC Group, Inc. EVC Group, Inc.
Sr. Vice President and CFO (415) 896-6820 (201) 646-5431
(425) 402-2009 (203) 570-4681
cgale@evcgroup.com

CSCX-G

SOURCE Cardiac Science Corporation

Mike Matysik, Sr. Vice President and CFO of Cardiac Science Corporation,
+1-425-402-2009; or Investors, Jenifer Kirtland, +1-415-896-6820, or Media,
Christopher Gale, +1-201-646-5431 , +1-203-570-4681, cgale@evcgroup.com, both
of EVC Group, Inc., for Cardiac Science Corporation